These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22395691)

  • 1. Public-private partnerships need honest brokering.
    Goldman M
    Nat Med; 2012 Mar; 18(3):341. PubMed ID: 22395691
    [No Abstract]   [Full Text] [Related]  

  • 2. The art of the alliance.
    Menzel GE; Xanthopoulos KG
    Nat Biotechnol; 2012 Apr; 30(4):313-5. PubMed ID: 22491275
    [No Abstract]   [Full Text] [Related]  

  • 3. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 4. Leveraging public private partnerships to innovate under challenging budget times.
    Portilla LM; Rohrbaugh ML
    Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What the Moderna-NIH COVID vaccine patent fight means for research.
    Ledford H
    Nature; 2021 Dec; 600(7888):200-201. PubMed ID: 34853416
    [No Abstract]   [Full Text] [Related]  

  • 6. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Universities shun Europe's drug initiative.
    Gilbert N
    Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
    [No Abstract]   [Full Text] [Related]  

  • 8. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 9. Funding bodies should foster partnerships between industry and academia.
    Tzircotis G; Hickson T; Foulkes I
    Nat Rev Cancer; 2021 Feb; 21(2):65-66. PubMed ID: 33398101
    [No Abstract]   [Full Text] [Related]  

  • 10. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 11. Is disclosure of potential conflicts of interest in medicine and public health sufficient to increase transparency and decrease corruption?
    Spelsberg A; Martiny A; Schoenhoefer PS;
    J Epidemiol Community Health; 2009 Aug; 63(8):603-5. PubMed ID: 19596840
    [No Abstract]   [Full Text] [Related]  

  • 12. Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
    Patel AC; Coyle AJ
    Clin Pharmacol Ther; 2013 Sep; 94(3):314-6. PubMed ID: 23645247
    [No Abstract]   [Full Text] [Related]  

  • 13. Europe's innovation hub finally KICs off.
    Gilbert N
    Nature; 2011 Feb; 470(7335):450. PubMed ID: 21350459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Laqueur and organon: the university laboratory and the pharmaceutical industry in the Netherlands].
    Oudshoorn N
    Tijdschr Geschied Geneeskd Natuurwet Wiskd Tech; 1999; 22(1):12-22. PubMed ID: 20677414
    [No Abstract]   [Full Text] [Related]  

  • 15. Playing well with others! Initiating and sustaining successful collaborations between industry, academia and government.
    Thomas CJ; McKew JC
    Curr Top Med Chem; 2014; 14(3):291-3. PubMed ID: 24283974
    [No Abstract]   [Full Text] [Related]  

  • 16. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 18. Pierre Meulien.
    Meulien P; Mullard A
    Nat Rev Drug Discov; 2015 Aug; 14(8):521. PubMed ID: 26228752
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: Medicare Part D. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447
    [No Abstract]   [Full Text] [Related]  

  • 20. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.
    Ingrosso L; Rezza G; Pocchiari M; Garaci E
    Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.